+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Autoimmune Disease Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • Acute Market Reports
  • ID: 6176328
Description Jump to:
The global veterinary autoimmune disease therapeutics market is projected to grow at a CAGR of 6.2% from 2025 to 2033. Growth is primarily driven by the rising prevalence of autoimmune disorders in companion animals, increasing pet adoption, and heightened awareness among veterinarians and pet owners regarding early diagnosis and treatment. As autoimmune diseases in animals often lead to chronic health issues and reduced quality of life, demand for targeted and effective therapeutics is increasing.

Rising Pet Ownership and Expanding Veterinary Care Fueling Growth

The growing trend of humanization of pets and rising expenditure on veterinary healthcare are supporting the adoption of advanced autoimmune therapeutics. Common diseases such as hypothyroidism, pemphigus, and canine lupus are increasingly diagnosed due to improved diagnostic technologies. Therapeutics including corticosteroids, cyclosporine, and mycophenolate remain first-line treatments, while newer immunosuppressive and targeted therapies are expanding treatment options. Veterinary clinics, specialty hospitals, and research institutions are adopting combination therapies to improve long-term disease management.

Market Challenges: Limited Availability of Specialized Drugs

High treatment costs, limited availability of advanced therapeutics in emerging markets, and the risk of adverse drug reactions pose challenges to market expansion. In addition, autoimmune disease diagnostics in animals are often complex, leading to delayed treatments. However, rising R&D investments in veterinary pharmaceuticals, expansion of tele-veterinary services, and the introduction of biosimilars and generics are expected to reduce these barriers over time.

Market Segmentation by Therapy Type

By therapy type, the market includes corticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide, levothyroxine, and other therapy types. Corticosteroids remain the most widely prescribed due to cost-effectiveness and efficacy in controlling inflammation. Cyclosporine and mycophenolate are increasingly adopted for long-term management with fewer side effects, while levothyroxine dominates hypothyroidism treatment. Azathioprine, leflunomide, and cyclophosphamide support niche applications in severe or resistant cases.

Market Segmentation by Disease

By disease, the market is segmented into hypothyroidism, pemphigus disease, canine lupus, autoimmune hemolytic anemia, bullous pemphigoid, discoid lupus erythematosus (DLE), immune-related arthritis, and other diseases. Hypothyroidism holds the largest share due to its high prevalence in dogs, particularly in middle-aged breeds. Pemphigus and canine lupus are steadily treated with immunosuppressive drugs, while autoimmune hemolytic anemia and DLE require aggressive therapeutic approaches. Immune-related arthritis is an emerging focus, reflecting the aging pet population and growing demand for chronic care management.

Regional Insights

In 2024, North America led the market due to high pet ownership, advanced veterinary care infrastructure, and strong presence of leading pharmaceutical companies. Europe followed, supported by comprehensive veterinary healthcare frameworks and insurance coverage for companion animals. Asia-Pacific is the fastest-growing region, with rising disposable incomes, increasing pet adoption in urban centers, and expanding veterinary hospitals in China, India, and Japan. Latin America and Middle East & Africa (MEA) are emerging regions, where growing awareness and expanding private veterinary services are creating new opportunities despite affordability constraints.

Competitive Landscape

The 2024 market featured a mix of global veterinary pharmaceutical leaders and specialized biotech firms. Zoetis, Elanco, and Merck led with broad therapeutic portfolios and global distribution. Virbac, Ceva Santé Animale, Dechra Pharmaceuticals, and Vetoquinol strengthened positions in Europe and emerging markets with diversified autoimmune therapeutics. Aratana Therapeutics and Vet-Stem contributed niche biologic and regenerative solutions. Heska and Norbrook expanded through partnerships and cost-effective product lines, while Mars Veterinary Health leveraged its veterinary clinic network for broad therapeutic adoption. Competitive strategies center on expanding product pipelines, improving safety profiles, regional expansion, and strategic collaborations.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Veterinary Autoimmune Disease Therapeutics market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users & consumption volume, price, and value
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Veterinary Autoimmune Disease Therapeutics market and their expected impact during the forecast period.
The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rates and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. The application of both a top-down and bottom-up approach for the validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

  • Therapy Type
    • Corticosteroids
    • Azathioprine
    • Cyclosporine
    • Mycophenolate
    • Leflunomide
    • Cyclophosphamide
    • Levothyroxine
    • Other therapy types

  • Disease
    • Hypothyroidism
    • Pemphigus disease
    • Canine lupus
    • Auto-immune hemolytic anemia
    • Bullous pemphigoid
    • Discoid lupus erythematosus (DLE)
    • Immune-related arthritis
    • Other diseases

  • Animal Type
    • Companion animals
      • Dogs
      • Cats
      • Horses
      • Other companion animals

    • Livestock animals
      • Cattle
      • Swine
      • Poultry
      • Sheep
      • Other livestock animals

    • Other animals

  • Route of Administration
    • Oral
    • Injectable
    • Topical

  • Distribution Channel
    • Veterinary hospitals
    • Veterinary clinics
    • Other distribution channels

Regional Segmentation (2023-2033; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Veterinary Autoimmune Disease Therapeutics market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Veterinary Autoimmune Disease Therapeutics market?
  • Which is the largest regional market for Veterinary Autoimmune Disease Therapeutics market?
  • What are the market trends and dynamics in emerging markets such as Asia-Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Veterinary Autoimmune Disease Therapeutics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Veterinary Autoimmune Disease Therapeutics market worldwide?

This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Veterinary Autoimmune Disease Therapeutics Market
2.2. Global Veterinary Autoimmune Disease Therapeutics Market, by Therapy Type, 2024 (US$ Million)
2.3. Global Veterinary Autoimmune Disease Therapeutics Market, by Disease, 2024 (US$ Million)
2.4. Global Veterinary Autoimmune Disease Therapeutics Market, by Animal Type, 2024 (US$ Million)
2.5. Global Veterinary Autoimmune Disease Therapeutics Market, by Route of Administration, 2024 (US$ Million)
2.6. Global Veterinary Autoimmune Disease Therapeutics Market, by Distribution Channel, 2024 (US$ Million)
2.7. Global Veterinary Autoimmune Disease Therapeutics Market, by Geography, 2024 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2024
3. Veterinary Autoimmune Disease Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Veterinary Autoimmune Disease Therapeutics Market Vendors
3.2. Strategies Adopted by Veterinary Autoimmune Disease Therapeutics Market Vendors
4. Veterinary Autoimmune Disease Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Veterinary Autoimmune Disease Therapeutics Market Value, 2023-2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 vs. 2033
5.3. Market Segmentation
5.3.1. Corticosteroids
5.3.2. Azathioprine
5.3.3. Cyclosporine
5.3.4. Mycophenolate
5.3.5. Leflunomide
5.3.6. Cyclophosphamide
5.3.7. Levothyroxine
5.3.8. Other therapy types
6. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 vs. 2033
6.3. Market Segmentation
6.3.1. Hypothyroidism
6.3.2. Pemphigus disease
6.3.3. Canine lupus
6.3.4. Auto-immune hemolytic anemia
6.3.5. Bullous pemphigoid
6.3.6. Discoid lupus erythematosus (DLE)
6.3.7. Immune-related arthritis
6.3.8. Other diseases
7. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 vs. 2033
7.3. Market Segmentation
7.3.1. Companion animals
7.3.1.1. Dogs
7.3.1.2. Cats
7.3.1.3. Horses
7.3.1.4. Other companion animals
7.3.2. Livestock animals
7.3.2.1. Cattle
7.3.2.2. Swine
7.3.2.3. Poultry
7.3.2.4. Sheep
7.3.2.5. Other livestock animals
7.3.3. Other animals
8. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2024 vs. 2033
8.3. Market Segmentation
8.3.1. Oral
8.3.2. Injectable
8.3.3. Topical
9. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2024 vs. 2033
9.3. Market Segmentation
9.3.1. Veterinary hospitals
9.3.2. Veterinary clinics
9.3.3. Other distribution channels
10. North America Veterinary Autoimmune Disease Therapeutics Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
10.3. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
10.4. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
10.5. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.6. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
10.7. Veterinary Autoimmune Disease Therapeutics Market: by Region, 2023-2033, USD (Million)
10.7.1. North America
10.7.1.1. U.S.
10.7.1.1.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
10.7.1.1.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
10.7.1.1.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
10.7.1.1.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.7.1.1.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
10.7.1.2.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
10.7.1.2.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
10.7.1.2.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.7.1.2.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
10.7.1.3.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
10.7.1.3.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
10.7.1.3.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.7.1.3.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
11. UK and European Union Veterinary Autoimmune Disease Therapeutics Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
11.3. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
11.4. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
11.5. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.6. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
11.7. Veterinary Autoimmune Disease Therapeutics Market: by Region, 2023-2033, USD (Million)
11.7.1. UK and European Union
11.7.1.1. UK
11.7.1.1.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
11.7.1.1.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
11.7.1.1.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
11.7.1.1.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.1.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
11.7.1.2.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
11.7.1.2.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
11.7.1.2.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.2.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
11.7.1.3.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
11.7.1.3.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
11.7.1.3.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.3.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
11.7.1.4.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
11.7.1.4.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
11.7.1.4.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.4.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
11.7.1.5. France
11.7.1.5.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
11.7.1.5.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
11.7.1.5.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
11.7.1.5.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.5.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
11.7.1.6.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
11.7.1.6.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
11.7.1.6.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.6.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
12. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
12.3. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
12.4. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
12.5. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.6. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
12.7. Veterinary Autoimmune Disease Therapeutics Market: by Region, 2023-2033, USD (Million)
12.7.1. Asia-Pacific
12.7.1.1. China
12.7.1.1.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
12.7.1.1.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
12.7.1.1.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
12.7.1.1.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.1.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
12.7.1.2.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
12.7.1.2.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
12.7.1.2.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.2.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
12.7.1.3. India
12.7.1.3.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
12.7.1.3.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
12.7.1.3.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
12.7.1.3.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.3.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
12.7.1.4.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
12.7.1.4.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
12.7.1.4.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.4.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
12.7.1.5.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
12.7.1.5.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
12.7.1.5.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.5.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
12.7.1.6. Rest of Asia-Pacific
12.7.1.6.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
12.7.1.6.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
12.7.1.6.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
12.7.1.6.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.6.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
13. Latin America Veterinary Autoimmune Disease Therapeutics Market, 2023-2033, USD (Million)
13.1. Market Overview
13.2. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
13.3. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
13.4. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
13.5. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.6. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
13.7. Veterinary Autoimmune Disease Therapeutics Market: by Region, 2023-2033, USD (Million)
13.7.1. Latin America
13.7.1.1. Brazil
13.7.1.1.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
13.7.1.1.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
13.7.1.1.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
13.7.1.1.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.7.1.1.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
13.7.1.2.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
13.7.1.2.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
13.7.1.2.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.7.1.2.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
13.7.1.3.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
13.7.1.3.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
13.7.1.3.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.7.1.3.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
14. Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market, 2023-2033, USD (Million)
14.1. Market Overview
14.2. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
14.3. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
14.4. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
14.5. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.6. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
14.7. Veterinary Autoimmune Disease Therapeutics Market: by Region, 2023-2033, USD (Million)
14.7.1. Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
14.7.1.1.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
14.7.1.1.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
14.7.1.1.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.7.1.1.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
14.7.1.2.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
14.7.1.2.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
14.7.1.2.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.7.1.2.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Veterinary Autoimmune Disease Therapeutics Market: by Therapy Type, 2023-2033, USD (Million)
14.7.1.3.2. Veterinary Autoimmune Disease Therapeutics Market: by Disease, 2023-2033, USD (Million)
14.7.1.3.3. Veterinary Autoimmune Disease Therapeutics Market: by Animal Type, 2023-2033, USD (Million)
14.7.1.3.4. Veterinary Autoimmune Disease Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.7.1.3.5. Veterinary Autoimmune Disease Therapeutics Market: by Distribution Channel, 2023-2033, USD (Million)
15. Company Profiles
15.1. Aratana Therapeutics
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
15.2. Dechra Pharmaceuticals
15.3. Elanco
15.4. Heska
15.5. Mars Veterinary Health
15.6. Merck
15.7. Norbrook
15.8. Vetoquinol
15.9. Vet-Stem
15.10. Virbac
15.11. Zoetis
15.12. Other Notable Players
List of Figures
Figure 1 Global Veterinary Autoimmune Disease Therapeutics Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Veterinary Autoimmune Disease Therapeutics Market: Quality Assurance
Figure 5 Global Veterinary Autoimmune Disease Therapeutics Market, by Therapy Type, 2024
Figure 6 Global Veterinary Autoimmune Disease Therapeutics Market, by Disease, 2024
Figure 7 Global Veterinary Autoimmune Disease Therapeutics Market, by Animal Type, 2024
Figure 8 Global Veterinary Autoimmune Disease Therapeutics Market, by Route of Administration, 2024
Figure 9 Global Veterinary Autoimmune Disease Therapeutics Market, by Distribution Channel, 2024
Figure 10 Global Veterinary Autoimmune Disease Therapeutics Market, by Geography, 2024
Figure 11 Market Geographical Opportunity Matrix - Global Veterinary Autoimmune Disease Therapeutics Market, 2024
Figure 12 Market Positioning of Key Veterinary Autoimmune Disease Therapeutics Market Players, 2024
Figure 13 Global Veterinary Autoimmune Disease Therapeutics Market, by Therapy Type, 2024 vs 2033, %
Figure 14 Global Veterinary Autoimmune Disease Therapeutics Market, by Disease, 2024 vs 2033, %
Figure 15 Global Veterinary Autoimmune Disease Therapeutics Market, by Animal Type, 2024 vs 2033, %
Figure 16 Global Veterinary Autoimmune Disease Therapeutics Market, by Route of Administration, 2024 vs 2033, %
Figure 17 Global Veterinary Autoimmune Disease Therapeutics Market, by Distribution Channel, 2024 vs 2033, %
Figure 18 U.S. Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 19 Canada Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 20 Rest of North America Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 21 UK Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 22 Germany Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 23 Spain Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 24 Italy Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 25 France Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 26 Rest of Europe Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 27 China Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 28 Japan Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 29 India Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 30 Australia Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 31 South Korea Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 32 Rest of Asia Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 33 Brazil Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 34 Mexico Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 35 Rest of Latin America Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 36 GCC Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 37 Africa Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
Figure 38 Rest of Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market (US$ Million), 2023-2033
List of Tables
Table 1 Global Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 2 Global Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 3 Global Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 4 Global Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 5 Global Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 6 North America Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 7 North America Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 8 North America Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 9 North America Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 10 North America Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 11 U.S. Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 12 U.S. Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 13 U.S. Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 14 U.S. Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 15 U.S. Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 16 Canada Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 17 Canada Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 18 Canada Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 19 Canada Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 20 Canada Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 21 Rest of North America Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 22 Rest of North America Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 23 Rest of North America Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 24 Rest of North America Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 25 Rest of North America Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 26 UK and European Union Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 27 UK and European Union Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 28 UK and European Union Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 29 UK and European Union Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 30 UK and European Union Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 31 UK Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 32 UK Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 33 UK Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 34 UK Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 35 UK Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 36 Germany Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 37 Germany Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 38 Germany Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 39 Germany Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 40 Germany Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 41 Spain Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 42 Spain Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 43 Spain Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 44 Spain Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 45 Spain Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 46 Italy Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 47 Italy Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 48 Italy Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 49 Italy Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 50 Italy Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 51 France Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 52 France Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 53 France Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 54 France Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 55 France Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 56 Rest of Europe Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 57 Rest of Europe Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 58 Rest of Europe Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 59 Rest of Europe Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 60 Rest of Europe Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 61 Asia Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 62 Asia Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 63 Asia Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 64 Asia Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 65 Asia Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 66 China Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 67 China Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 68 China Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 69 China Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 70 China Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 71 Japan Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 72 Japan Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 73 Japan Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 74 Japan Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 75 Japan Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 76 India Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 77 India Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 78 India Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 79 India Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 80 India Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 81 Australia Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 82 Australia Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 83 Australia Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 84 Australia Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 85 Australia Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 86 South Korea Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 87 South Korea Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 88 South Korea Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 89 South Korea Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 90 South Korea Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 91 Latin America Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 92 Latin America Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 93 Latin America Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 94 Latin America Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 95 Latin America Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 96 Brazil Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 97 Brazil Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 98 Brazil Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 99 Brazil Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 100 Brazil Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 101 Mexico Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 102 Mexico Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 103 Mexico Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 104 Mexico Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 105 Mexico Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 106 Rest of Latin America Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 107 Rest of Latin America Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 108 Rest of Latin America Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 109 Rest of Latin America Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 110 Rest of Latin America Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 111 Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 112 Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 113 Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 114 Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 115 Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 116 GCC Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 117 GCC Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 118 GCC Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 119 GCC Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 120 GCC Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 121 Africa Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 122 Africa Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 123 Africa Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 124 Africa Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 125 Africa Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)
Table 126 Rest of Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Therapy Type, 2023-2033, USD (Million)
Table 127 Rest of Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Disease, 2023-2033, USD (Million)
Table 128 Rest of Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Animal Type, 2023-2033, USD (Million)
Table 129 Rest of Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 130 Rest of Middle East and Africa Veterinary Autoimmune Disease Therapeutics Market by Distribution Channel, 2023-2033, USD (Million)

Companies Mentioned

The key companies featured in this Veterinary Autoimmune Disease Therapeutics market report include:
  • Aratana Therapeutics
  • Dechra Pharmaceuticals
  • Elanco
  • Heska
  • Mars Veterinary Health
  • Merck
  • Norbrook
  • Vetoquinol
  • Vet-Stem
  • Virbac
  • Zoetis

Related Topics

Related Reports

Veterinary Autoimmune Disease Therapeutics Global Market Report 2025 - Product Image

Veterinary Autoimmune Disease Therapeutics Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Veterinary Immunomodulators Market - Global Forecast 2025-2030 - Product Image

Veterinary Immunomodulators Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Veterinary Endocrinology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Veterinary Endocrinology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 175 Pages
  • Global
From
Veterinary Dermatology Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Veterinary Dermatology Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 130 Pages
  • Global
From
Introduction to Diseases, Diagnosis, and Management of Dogs and Cats. Developments in Microbiology - Product Image

Introduction to Diseases, Diagnosis, and Management of Dogs and Cats. Developments in Microbiology

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.